Cite

HARVARD Citation

    Imai, H. et al. (2018). A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations. Lung cancer. pp. 41-47. [Online]. 
  
Back to record